G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2011
10/20/2011	US20110256553 Methods
10/20/2011	US20110256552 Method for preparing a substrate for immobilizing a cell, said substrate and uses thereof
10/20/2011	US20110256551 Systems and devices for analysis for samples
10/20/2011	US20110256549 Novel reagents for directed biomarker signal amplification
10/20/2011	US20110256548 Method for obtaining pancreatic progenitor cell using neph3
10/20/2011	US20110256539 Methods for Detecting Tumor Origin Based on MUC1, MUC2, and CK-17 Expression Levels
10/20/2011	US20110256536 Two stage nucleic acid amplification using an amplification oligomer
10/20/2011	US20110256535 Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantification, monitoring, screening and sequencing of clostridium difficile genes encoding toxin b, and/or toxin a and/or binary toxin
10/20/2011	US20110256533 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance
10/20/2011	US20110256531 Biodetection articles
10/20/2011	US20110256526 Detection of human somatic cell reprogramming
10/20/2011	US20110256525 Compositions and methods for purifying and crystallizing molecules of interest
10/20/2011	US20110256248 Antioxidant Compositions and Methods Thereto
10/20/2011	US20110256180 Factor H Binding Proteins (FHBP) with Altered Properties and Methods of Use Thereof
10/20/2011	US20110256169 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
10/20/2011	US20110256165 Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis
10/20/2011	US20110256152 Methods Of Treating And Preventing Glucose Toxicity
10/20/2011	US20110256147 Diagnostic and treatment methods for cancer based on immune inhibitors
10/20/2011	US20110256138 Amyloid-beta binding proteins
10/20/2011	US20110256131 BLOCKERS OF LIGHT, LTalpha1beta2 AND LTalpha2beta1 OR ITS RECEPTOR LTbetaR FOR THE PREVENTION AND TREATMENT OF CHRONIC HEPATITIS AND OTHER LIVER DISEASES
10/20/2011	US20110256113 Method for preventing and treating diabetes using neurturin
10/20/2011	US20110256110 Amniotic fluid cells and uses thereof
10/20/2011	US20110256094 Methods and Compositions for Chlamydial Antigens for Diagnosis and Treatment of Chlamydial Infection and Disease
10/20/2011	US20110256064 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
10/20/2011	US20110256063 Mex3c regulation and target to control obesity and diabetes
10/20/2011	US20110256062 Methods
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011	US20110256060 Monoclonal antibody and its use for the identification of the oncofetal isoform of fibronectin (b-fn) for diagnosis or therpay
10/20/2011	US20110256058 Novel Peptides and Uses Thereof
10/20/2011	US20110256056 Monoclonal Antibodies Against HER2 Antigens, and Uses Therefor
10/20/2011	US20110256055 Application of 99mtc peptide-based compound as a bone marrow imaging agent
10/20/2011	US20110256025 Immunoassay product and process
10/20/2011	US20110256023 Sample plate for a biochemical analyzer
10/20/2011	US20110256022 Automatic analyzer
10/20/2011	US20110253536 Method for increasing measurement precision of two-dimensional protein
10/20/2011	US20110253533 Device and method for determining analyte levels
10/20/2011	US20110253532 Analyte Meter Protectors and Methods
10/20/2011	US20110252900 Measurement apparatus for vacuum therapy systems for wound treatment
10/20/2011	US20110252899 Vessel inspection apparatus and methods
10/20/2011	US20110252870 Method for monitoring a linear guide
10/20/2011	US20110252867 Method for diagnosing the performance of a catalytic converter
10/20/2011	DE102010027946A1 Überwachungssysten für einen Kühlmittelkreislauf Überwachungssysten for a coolant circuit
10/20/2011	DE102010027818A1 Measuring system for determining material index characterizing printing properties from plastics, has control device determining printing properties of strand from measurement signal, and press member opposite to pressure element
10/20/2011	DE102010015636A1 Vorrichtung und ein Verfahren zum Feststellen des Alterungszustands einer Hydraulikflüssigkeit eines Hydrauliksystems eines Fahrzeugs An apparatus and a method for determining the aging state of a hydraulic fluid of a hydraulic system of a vehicle
10/20/2011	DE102010015192A1 Verfahren zur biokompatiblen Verbindung einer multifunktionalen PTFE-Membran oder -Folie mit einem Kunststoffteil A method for connecting a multifunctional biocompatible PTFE membrane or film having a plastic part
10/20/2011	CA2796317A1 New methods for isolating tr1 cells
10/20/2011	CA2796306A1 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (alk) kinase inhibitors
10/20/2011	CA2796277A1 Tumor cell-derived microvesicles
10/20/2011	CA2796268A1 Methods for treatment of sleep-related breathing disorders
10/20/2011	CA2796217A1 Biomarkers based on a multi-cancer invasion-associated mechanism
10/20/2011	CA2796180A1 Monoclonal antibodies against her2 antigens, and uses therefor
10/20/2011	CA2796003A1 Method for diagnosis of multiple sclerosis involving anti-at1-receptor antibody
10/20/2011	CA2795919A1 Reagents and methods for phosphorylation/dephosphorylation analyses
10/20/2011	CA2795901A1 Methods and compositions for diagnosing pulmonary fibrosis subtypes and assessing the risk of primary graft dysfunction after lung transplantation
10/20/2011	CA2795643A1 Methods for generating endogenously tagged protein
10/20/2011	CA2795325A1 Fibronectin type iii domain-based multimeric scaffolds
10/20/2011	CA2795270A1 Diagnostic methods for glaucoma
10/20/2011	CA2795070A1 Compositions and methods for characterizing a myopathy
10/20/2011	CA2794840A1 Method and kit for cancer diagnosis
10/20/2011	CA2793892A1 Foxo3a as predictive biomarker for pi3k/akt kinase pathway inhibitor efficacy
10/20/2011	CA2793490A1 Method for differentially quantifying naturally processed hla-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
10/20/2011	CA2793487A1 Biomarkers for hypertensive disorders of pregnancy
10/20/2011	CA2738050A1 Method for scanning the internal quality of logs
10/19/2011	EP2378291A1 Lacosamide detection assay
10/19/2011	EP2378290A1 Diagnosis and risk stratification of infections and chronic illnesses of the airways and lungs by means of Pro-Vasopressin, in particular Copeptin or Neurophysin II
10/19/2011	EP2378289A1 Method for measuring systemic concentration of protein-containing medicament
10/19/2011	EP2378288A1 Unnatural reactive amino acid genetic code additions
10/19/2011	EP2378287A1 New method for isolating Tr1 cells
10/19/2011	EP2378277A2 Sensor and method for online monitoring of the acid value of a hydraulic fluid in an hydraulics system in an aircraft
10/19/2011	EP2378276A1 Quantitative, multispectral image analysis of tissue specimens stained with quantum dots
10/19/2011	EP2378275A1 Quantitative, multispectral image analysis of tissue specimens stained with quantum dots
10/19/2011	EP2378146A2 Method for monitoring a linear guide
10/19/2011	EP2377950A1 Gene expression markers for colorectal cancer prognosis
10/19/2011	EP2377947A1 Method for detecting cancer cells in blood sample
10/19/2011	EP2377936A2 Method for isolation of soluble polypeptides
10/19/2011	EP2377935A1 Method for isolation of soluble polypeptides
10/19/2011	EP2377921A1 Method for obtaining pancreatic progenitor cell using neph3
10/19/2011	EP2377891A1 Diagnosis and treatment of cancer using anti-lgr7 antibody
10/19/2011	EP2377876A1 Use of proteins and peptides of the TGF-BETA superfamily for purification and therapeutic methods
10/19/2011	EP2377572A1 A bio-hybrid implant for connecting a neural interface with a host nervous system
10/19/2011	EP2377559A1 Targeting cells with altered microRNA expression
10/19/2011	EP2377465A1 Biological information measurement device, illumination method in a biological information measurement device, and biological information measurement method
10/19/2011	EP2376926A1 Biomarkers for insulin sensitizer drug response
10/19/2011	EP2376925A1 Method for evaluating the immunogenicity of proteins
10/19/2011	EP2376924A1 Characterising planar samples by mass spectrometry
10/19/2011	EP2376923A2 Methods for detection of sepsis
10/19/2011	EP2376922A1 Antigenic polypeptides of chlamydia-related bacteria for diagnosis and vaccine
10/19/2011	EP2376921A1 Detection of ifi16 in body fluids
10/19/2011	EP2376920A1 Methods of detection of changes in cells
10/19/2011	EP2376919A1 Combined natriuretic peptide assays
10/19/2011	EP2376918A1 Detection device
10/19/2011	EP2376917A1 New receptor binding ligands, their use in the detection of cells with biological interest
10/19/2011	EP2376916A2 Quantification of non-reducing end glycan residual compounds
10/19/2011	EP2376915A2 Detection of oligosaccharides
10/19/2011	EP2376914A2 Methods for the characterization of microorganisms on solid or semi-solid media
10/19/2011	EP2376913A1 Detection of cancer through breath comprising a sensor array comprising capped conductive nanoparticles
10/19/2011	EP2376912A1 Method and apparatus for alcohol concentration detection in a blood sample
10/19/2011	EP2376911A1 Folded carrier tape having consumable elements
10/19/2011	EP2376910A2 Organic chemical sensor with microporous organosilicate material
10/19/2011	EP2376909A2 A state sensor

1 ... 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 ... 3937